Invictus RG (Singapore)’s Edwards Lifesciences EW Stock Holding History

Invictus RG (Singapore)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,186	Closed	-$76K	–	646
2015 Q2	$76K	Sell	3,186 -21,072	-87%	-$476K	0.07%	339
2015 Q1	$576K	Sell	24,258 -25,962	-52%	-$582K	0.55%	35
2014 Q4	$1.07M	Buy	50,220 +20,574	+69%	+$413K	1.16%	2
2014 Q3	$505K	Sell	29,646 -6,072	-17%	-$95.8K	0.64%	11
2014 Q2	$511K	Buy	35,718 +34,038	+2,026%	+$461K	0.53%	25
2014 Q1	$21K	Buy	+1,680	New	+$19.4K	0.02%	445

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invictus RG (Singapore)'s EW Position: Q3 2015 in Review

Invictus RG (Singapore) sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 3,186 shares — an estimated $76K sold.

Invictus RG (Singapore) first reported a position in EW in Q1 2014 and held it in 6 quarters. The position peaked at $1.07M in Q4 2014. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

Invictus RG (Singapore) reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 3,186 Edwards Lifesciences shares in Q3 2015, an estimated $76K.
Invictus RG (Singapore) first reported a position in Edwards Lifesciences in Q1 2014 and held it in 6 quarters.
Invictus RG (Singapore)'s Edwards Lifesciences position peaked at $1.07M in Q4 2014.
569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q3 2015, filed 13 Nov 2015.